SCI Cancer Clinical Trials Office Blog

News & Updates from the SCI-CCTO
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
  • Cancer Clinical Trials Office
  • Stanford Cancer Institute

Welcome to the CCTO!

February 8, 2022 - SCI Communications

Esther Kimani

The CCTO welcomes Esther Kimani, our new Research Analyst 3  with Finance. Esther graduated from The College of New Jersey with a M.Ed. and she also has an MBA from Colorado Technical University. Prior to joining the CCTO, Esther was a Program Manager at Hoover Institution and a Finance Analyst at the Global Center for Gender Equality at Stanford. She is excited to join the CCTO Finance team and is looking forward to growing professionally. Outside of work,  Esther loves listening to gospel music, both domestic and international. She also enjoys traveling and cooking. Please help us welcome Esther!

Ghazal Jawed

The CCTO welcomes Ghazal Jawed, our new CRCA with Sarcoma. Ghazal graduated from Transylvania University with a BA in Neuroscience and a minor in music. Prior to joining the CCTO, She worked at Stanford Health Care as a Patient Flow Coordinator in the Cancer Center. She is excited to contribute to cancer clinical research and gain more knowledge about the different types of sarcoma. Ghazal moved to California from Kentucky 1.5 years ago with her beloved cat, Rin. Her primary instrument is the French horn. Please help us welcome Ghazal!

Blog Submissions

If you have an announcement for the blog, please complete the Comms Request Form.

Reminder: Please have your blog post submitted to us by noon on Wednesday in order to have your post featured in the weekly email digest on Friday morning.

Archives

Categories

  • Announcements
  • Clinical Trials
  • Coordinator Corner
  • Educational Training
  • Events
  • Intake Process
  • IRB Updates
  • kudos
  • OnCore
  • PRISM
  • Quality Corner
  • Regulatory Updates
  • Remote Monitoring
  • SCI Messages
  • Scientific Review Committee (SRC)
  • SOP/Guideline Updates
  • Staff Updates
  • Uncategorized
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube